Skip to main content
. 2018 Jan 7;4(1):e000596. doi: 10.1136/rmdopen-2017-000596

Table 2.

Treatment at 3, 5 and 8 years from baseline (n (%))

3 years n=625 5 years n=625 8 years n=454
Still on initial TNFi 385 (61) 292 (47) 150 (33)
Started a second TNFi within period 168 (27) 229 (37) 264 (42)
On second TNFi at time point 110 (18) 124 (20) 72 (16)
Started a third TNFi within period 39 (6) 62 (10) 96 (15)
On third or subsequent TNFi at time point 35 (6) 44 (7) 53 (12)
Started non-TNFi biologic within period 4 (0.6) 9 (1) 19 (3)
On other non-TNFi biologic treatment at time point 2 (0.3) 3 (0.5) 8 (2)
Not on biologic treatment 68 (11) 77 (12) 45 (10)
Died 10 (2) 23 (4) 34 (8)
Lost to follow-up 15 (2) 62 (10) 92 (20)